ResMed Revenue and Competitors
Estimated Revenue & Valuation
- ResMed's estimated annual revenue is currently $3.4B per year.
- ResMed's estimated revenue per employee is $372,595
- ResMed's total funding is $500M.
- ResMed's current valuation is $36.7B. (January 2022)
Employee Data
- ResMed has 8991 Employees.
- ResMed grew their employee count by 8% last year.
ResMed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Distribution Product Owner | Reveal Email/Phone |
2 | CEO ResMed Healthcare, Germany | Reveal Email/Phone |
3 | Founder and Executive Chairman | Reveal Email/Phone |
4 | Chief Communications and Investor Relations Officer | Reveal Email/Phone |
5 | Executive Assistant to President, SaaS | Reveal Email/Phone |
6 | Chief Administrative Officer, Global General Counsel | Reveal Email/Phone |
7 | Chief Staff to SaaS CTO | Reveal Email/Phone |
8 | Executive Assistant to President, Sleep & Respiratory Care | Reveal Email/Phone |
9 | Executive Assistant to Chief Strategy Officer | Reveal Email/Phone |
10 | Head Finance, Business Unit CFO, ResMed SaaS | Reveal Email/Phone |
ResMed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.3M | 49 | 9% | N/A | N/A |
What Is ResMed?
The global team at ResMed (NYSE:RMD) is united in the commitment to change millions of lives with every breath. With more than 4,000 employees and a presence in over 100 countries, the company has been pioneering new and innovative devices and treatments for sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases for more than 25 years. ResMed's world-leading products and innovative solutions improve the quality of life for millions of patients worldwide, reduce the impact of chronic disease, and save healthcare costs. For more information about ResMed and its businesses.
keywords:N/A
$500M
Total Funding
8991
Number of Employees
$3.4B
Revenue (est)
8%
Employee Growth %
$36.7B
Valuation
N/A
Accelerator
ResMed News
Shares of ResMed Inc. RMD, +3.20% rose 3.20% to $239.42 Tuesday, on what proved to be an all-around great trading session for the stock...
Shares of ResMed Inc. RMD, +2.78% shed 0.95% to $231.99 Monday, on what proved to be an all-around poor trading session for the stock market...
ResMed is still maintaining its estimate that it will see between $300 million and $350 million in fiscal 2022 incremental revenue as a...
Mick Farrell is ResMed's CEO. During Q1, the company introduced the AirSense 11 in the U.S. San Diego-based ResMed (NASDAQ: RMD) posted strong quarterly results last week, beating analysts’ estimates even as ongoing supply chain bottlenecks slowed delivery and sales of the company’s marketing-le ...
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Wednesday, November 10, 2021, beginning at approximately 1:00 p.m ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3210.8M | 9361 | -6% | N/A |
#2 | $750M | 9473 | 5% | N/A |
#3 | $4621.6M | 10718 | 2% | N/A |
#4 | $4280M | 11139 | -4% | $28M |
#5 | $2244.6M | 11452 | -1% | N/A |